Remove Containment Remove Insulin Remove Research
article thumbnail

The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars

Drug Channels

Each exclusion list now contains about 600 products. Below, I highlight four takeaways from this year’s lists, including a look at biosimilar insulin and the forthcoming biosimilar competition for Humira. I also note some troubling research on the patient impact of exclusions—although much remains unknown.

Insulin 98
article thumbnail

The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars (rerun)

Drug Channels

Each exclusion list now contains about 600 products. Below, I highlight four takeaways from this year’s lists, including a look at biosimilar insulin and the forthcoming biosimilar competition for Humira. I also note some troubling research on the patient impact of exclusions—although much remains unknown.

Insulin 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Researchers Develop World’s First Saliva Test for Diabetes

XTalks

University of Newcastle researchers in Australia have developed a saliva test to evaluate glucose levels in diabetic patients. The test involves the use of testing strips that contain a glucose biosensor with electronic elements in the test’s transistor, like inks, that allow for mass printing of the test strips at low cost.

article thumbnail

The US biosimilar market: Predictions for 2021

pharmaphorum

Research also shows that embracing biosimilars and patient choice will lead to the competition needed to further increase access to both biosimilars and biologics for 1.2 One of these markets is the insulin market. Up until now, the insulin market has experienced little competition and, as a result, prices have soared over the years.

Marketing 119
article thumbnail

New Soliqua® data shows improved blood sugar control without weight gain versus premixed insulin

The Pharma Data

New Soliqua ® * data shows improved blood sugar control without weight gain versus premixed insulin. Study also shows more people on Soliqua had improved blood sugar control without weight gain and without low blood sugar events (hypoglycemia) in first head-to-head comparison with premixed insulin.

Insulin 52
article thumbnail

Lilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes | Eli Lilly and Company

The Pharma Data

The Tempo Pen is a modified version of Lilly ‘s existing prefilled, disposable insulin pen to which the Tempo Smart Button – pending CE (Conformité Européenne or European Conformity) marking – attaches. Diabetes is a chronic disease that occurs when the body does not properly produce or use the hormone insulin. About DexCom Inc.

Insulin 52
article thumbnail

Can Fruit Lower the Risk of Type 2 Diabetes?

XTalks

Researchers at the Edith Cowan University’s (ECU) Institute for Nutrition Research in Perth, Australia found that consuming at least two servings of fruit a day was linked to 36 percent lower odds of developing type 2 diabetes. A new Australian study suggests that eating fruit may lead to a reduced risk of developing type 2 diabetes.

Insulin 59